Clinuvel Pharmaceuticals Ltd (CUV) — Cash Flow-to-Debt Ratio
Clinuvel Pharmaceuticals Ltd (CUV) has a Cash Flow-to-Debt Ratio of 0.61x as of December 2025, meaning its operating cash flow of AU$12.52 Million could theoretically repay 1% of its total liabilities (AU$20.68 Million) in one year. Explore Clinuvel Pharmaceuticals Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Clinuvel Pharmaceuticals Ltd Cash Flow-to-Debt Ratio (2001–2025)
Historical debt coverage capacity for Clinuvel Pharmaceuticals Ltd across 24 annual periods. Also explore Clinuvel Pharmaceuticals Ltd assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Clinuvel Pharmaceuticals Ltd (2001–2025)
Year-by-year debt coverage analysis for Clinuvel Pharmaceuticals Ltd. For market capitalisation and broader financial context, see Clinuvel Pharmaceuticals Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.33x | AU$41.10 Million | AU$30.94 Million | ▲ +0.8% |
| 2024 | 1.32x | AU$37.05 Million | AU$28.11 Million | ▲ +6.7% |
| 2023 | 1.23x | AU$36.91 Million | AU$29.89 Million | ▼ -40.4% |
| 2022 | 2.07x | AU$39.87 Million | AU$19.25 Million | ▲ +5.7% |
| 2021 | 1.96x | AU$19.26 Million | AU$9.83 Million | ▲ +30.9% |
| 2020 | 1.50x | AU$14.19 Million | AU$9.48 Million | ▼ -58.1% |
| 2019 | 3.57x | AU$18.46 Million | AU$5.17 Million | ▲ +6.6% |
| 2018 | 3.35x | AU$11.69 Million | AU$3.49 Million | ▲ +6.9% |
| 2017 | 3.14x | AU$9.92 Million | AU$3.16 Million | ▲ +243.4% |
| 2016 | -2.19x | AU$-5.04 Million | AU$2.30 Million | ▼ -17.7% |
| 2015 | -1.86x | AU$-4.53 Million | AU$2.44 Million | ▲ +33.3% |
| 2014 | -2.79x | AU$-4.81 Million | AU$1.73 Million | ▲ +20.1% |
| 2013 | -3.49x | AU$-6.89 Million | AU$1.98 Million | ▲ +17.9% |
| 2012 | -4.25x | AU$-10.02 Million | AU$2.36 Million | ▼ -68.3% |
| 2011 | -2.52x | AU$-9.49 Million | AU$3.76 Million | ▲ +34.0% |
| 2010 | -3.82x | AU$-11.78 Million | AU$3.08 Million | ▼ -58.9% |
| 2009 | -2.41x | AU$-10.99 Million | AU$4.56 Million | ▼ -5.8% |
| 2008 | -2.28x | AU$-7.18 Million | AU$3.16 Million | ▲ +32.3% |
| 2007 | -3.36x | AU$-8.18 Million | AU$2.43 Million | ▲ +9.1% |
| 2006 | -3.70x | AU$-11.40 Million | AU$3.08 Million | ▼ -4.1% |
| 2005 | -3.55x | AU$-9.25 Million | AU$2.60 Million | ▲ +17.5% |
| 2004 | -4.31x | AU$-6.00 Million | AU$1.39 Million | ▲ +63.5% |
| 2002 | -11.81x | AU$-2.49 Million | AU$210.83K | ▼ -630.6% |
| 2001 | -1.62x | AU$-514.54K | AU$318.26K | — |